β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature

β-Blockers (BBs) are an essential class of cardiovascular medications for reducing morbidity and mortality in patients with heart failure (HF). However, a large body of data indicates that BBs should not be used as first-line therapy for hypertension (HTN). Additionally, new data have questioned the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Heart
Main Authors: DiNicolantonio, James J, Fares, Hassan, Niazi, Asfandyar K, Chatterjee, Saurav, D'Ascenzo, Fabrizio, Cerrato, Enrico, Biondi-Zoccai, Giuseppe, Lavie, Carl J, Bell, David S, O'Keefe, James H
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2015
Assuntos:
Cardiac Risk Factors and Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4371808/
https://ncbi.nlm.nih.gov/pubmed/25821584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2014-000230
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados